Skip to main content
. 2017 Apr 10;13(6):4002–4012. doi: 10.3892/ol.2017.6016

Table I.

Ocoxin oral solution (OOS®), irinotecan and the combined therapy deregulated genes.

Up Down Total
OOS® vs. control 30     5   35
Irinotecan vs. control 11 141 152
OOS®+irinotecan vs. control   5     1     6
OOS®+irinotecan vs. irinotecan 14     0   14